US launch Mythocondro: a non-animal chondroitin sulphate

Published: 17-Nov-2017
Ingredients Active Nutrition Food

The American market has started to launch the first dietary supplements with Mythocondro, the unique 100% vegan chondroitin sulfate similar to human synovial fluid, manufactured by Gnosis

Mythocondro is the first non-animal chondroitin sulphate product on the market obtained through the exclusive natural fermentative production process developed by Gnosis.

The result of this innovative approach is a 100% vegan product, suitable for vegetarians and free from restrictions of use related to religious and supply issues.

Mythocondro radically and definitely solves the long-standing, undisputed problems of poor quality and potential safety issues of animal-derived chondroitin sulphate.

Its natural origin not only makes the product suitable for everyone, but also guarantees a reliable and reproducible source of chondroitin sulphate, highly pure (99% by HPLC) with demonstrated great bioavailability, efficacy and safety.

  • Companies:
  • Gnosis by Lesaffre
See more

You may also like

Ingredients

SAMe holds promise for depression, studies find

Read more
Two novel studies have suggested S-Adenosylmethionine (SAMe) could be a beneficial monotherapy for patients with depression

Trending Articles

  1. Arla Foods Ingredients new beverage concept for nutrition-conscious gamers The energy drink contains 15g of protein, taurine, magnesium, zinc, caffeine and vitamins A, B3, B6 and B12
  2. The power of the pomegranate in bolstering gut health Supplementation with Punica granatum extract can help to enhance gut health in three ways, a novel study finds
  3. Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight

Upcoming event

Vitafoods Europe

14–16 May 2024 | Exhibition | Palexpo, Geneva See all

You may also like

Ingredients

SAMe holds promise for depression, studies find

Two novel studies have suggested S-Adenosylmethionine (SAMe) could be a beneficial monotherapy for patients with depression
Ingredients

SunWay Biotech and Gnosis by Lesaffre form alliance to launch MenaQ7 Metabolic

The novel product will be aimed at the lucrative vitamin K2 market
Ingredients

Vitamin K2 could be at the heart of a healthy lifestyle

Further evidence highlights the impact of essential nutrients on cardiovascular health, including potential $9.48B a year in healthcare cost savings
Ingredients

Gnosis vitamin K2 scientific advisory committee grows and holds first meeting

The inaugural meeting of the Gnosis K2SAC welcomed new members and focused on the exciting future for K2
Ingredients

Gnosis by Lesaffre launches MenaQ7 Protect

A collaboration between Gnosis and Probiotical creates the first private-label, ready-to-market, immune-support supplement featuring clinically validated MenaQ7 K2
Ingredients

New MenaQ7 K2 cardio study in kidney patients published

TReVasc-HDK Trial examined the efficacy of K2 supplementation in reducing vascular calcification progression in haemodialysis patients, offering new insights on appropriate dosing
Ingredients

New study highlights the impact of proactive bone health strategies

Research shows how increasing bone mineral density by 3% equates to a 45% reduction in hip fractures
Subscribe now